ICT-107

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:29 am
ImmunoCellular Therapeutics
ICT-107
glioblastoma
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
TheStreet.com
Mon, 03/3/14 - 11:55 am
glioblastoma multiforme
DCVax
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics
ImmunoCellular: Is Approval Enough?
Seeking Alpha
Mon, 02/24/14 - 11:12 am
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
glioblastoma multiforme
Focus On Cancer Immunotherapy Results
Seeking Alpha
Sat, 01/25/14 - 10:58 am
cancer immunotherapy
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
Immunocellular Shares Are Set For A Rebound
Seeking Alpha
Fri, 12/20/13 - 08:37 am
ImmunoCellular Therapeutics
ICT-107
Northwest Biotherapeutics
Why Northwest Bio's DCVax Brain Tumor Vaccine Will Blow Up Just Like ImmunoCellular's ICT-107
TheStreet.com
Tue, 12/17/13 - 08:50 am
Northwest Biotherapeutics
DCVax
ICT-107
glioblastoma multiforme
ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
Seeking Alpha
Mon, 12/16/13 - 07:32 am
ICT-107
ImmunoCellular
Northwest Biotherapeutics
ImmunoCellular's ICT-107 Phase II: Patience Will Pay Off
Seeking Alpha
Wed, 12/11/13 - 11:21 am
ImmunoCellular Therapeutics
ICT-107
glioblastoma multiforme
Celldex, ImmunoCellular Fall And Rise On Hype And Hope
Seeking Alpha
Wed, 11/27/13 - 08:31 am
ImmunoCellular Therapeutics
Celldex
rindopepimut
glioblastoma
ICT-107
ImmunoCellular Therapeutics Soars on Positive Brain Cancer Data
Wall St Cheat Sheet
Mon, 11/25/13 - 05:30 pm
ImmunoCellular Therapeutics
glioblastoma multiforme
brain cancer
ICT-107
ImmunoCellullar Therapeutics' Immune Modifying Approach To Cancer Is Worth Watching
Seeking Alpha
Tue, 07/2/13 - 01:36 am
ImmunoCellular Therapeutics
cancer
Dendreon
ICT-107
ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107
Seeking Alpha
Wed, 03/27/13 - 12:00 pm
ImmunoCellular Therapeutics
Dendreon
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics: Explaining The Benefits Of A Multiple Antigen Targeting Approach
Seeking Alpha
Mon, 07/23/12 - 08:56 am
ImmunoCellular Therapeutics
glioblastoma
ICT-107
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thu, 10/27/11 - 01:40 pm
vaccines
ICT-107
glioblastoma
ImmunoCellular
VGX-3100
Inovio
cervical cancer
MAGE-A3
GSK
skin cancer
lung cancer
NeuVax
breast cancer
RXi Pharmaceuticals
Antigen Express
AE37
Nexvax2
celiac disease
ImmusanT
ADXS-HPV
head and neck cancer
Advaxis
GI-4000
GlobeImmune
pancreatic cancer
PEV7
Pevion Biotech
ImmunoCellular Therapeutics: The Biotechnology Moneyball
Seeking Alpha
Thu, 10/6/11 - 09:34 am
ImmunoCellular
ICT-107
GBM
glioblastoma multiforme
brain cancer
Navigating Cancer Vaccines' High-Risk/High-Reward Field
Seeking Alpha
Wed, 08/17/11 - 12:09 pm
cancer
vaccines
Dendreon
Provenge
ICT-107
ImmunoCellular
Amgen
ImmunoCellular Therapeutics’ ICT-107 Named One of the 100 Great Investigational Drugs for 2011
Thu, 03/31/11 - 12:53 pm
ImmunoCellular Therapeutics
ICT-107
investigational drugs
glioblastoma multiforme
cancer vaccines
ImmunoCellular Therapeutics (IMUC) : At the Forefront of Targeting Cancer Stem Cells (II)
Wed, 12/1/10 - 04:26 pm
ImmunoCellular
cancer stem cells
Provenge
ICT-107
investors